MedPath

effects of gingko biloba on the outcomes of metabolic syndrome

Phase 3
Conditions
metabolic syndrome.
Metabolic syndrome
E88.81
Registration Number
IRCT20200803048285N1
Lead Sponsor
College of Pharmacy / University of Sulaimani
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

newly diagnosed as Metabolic syndrome
both sexes

Exclusion Criteria

pregnancy
ischemic heart disease
G6PD Deficiency
bleeding disorders
seizures
allergy to the medications used in this trial

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath